Foamix Pharmaceuticals (FOMX) stock is up more than 29% over the past week. FOMX stock is down -47.04% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives FOMX stock a score of 76 out of a possible 100.
That score is chiefly influenced by a fundamental score of 87. In addition to the average rating from Wall Street analysts, FOMX stock has a mean target price of $15.60. This means analysts expect the stock to rise 398.40% over the next 12 months. FOMX’s score also includes a short-term technical score of 81. The long-term technical score for FOMX is 61.
What’s Happening with FOMX Stock Today
Foamix Pharmaceuticals Ltd (FOMX) stock has gained 16.79% while the S&P 500 has gained 1.25% as of 11:31 AM on Tuesday, Aug 13. FOMX has gained $0.45 from the previous closing price of $2.68 on volume of 989,319 shares. Over the past year the S&P 500 is higher by 3.44% while FOMX is down -47.04%. FOMX lost -$1.26 per share in the over the last 12 months.